Bridging Study of L059 (Levetiracetam) in Patients With Epilepsy by Double Blind Method

NCT00600509 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

216

Enrollment

INDUSTRY

Sponsor class

Conditions

Epilepsy

Interventions

DRUG: Levetiracetam

Sponsor

UCB Pharma

Collaborators

[object Object]